Heart failure with preserved ejection fraction (HFpEF) is a complex clinical syndrome in
which sex-specific features due to anatomical, physiological, and hormonal characteristics …

Objective Cardiac amyloidosis (CA) is an increasingly recognised condition in patients with
aortic stenosis (AS). However, there is a large variation in the reported prevalence figures …

These guidelines form an update of the BSE guideline protocol for the assessment of
restrictive cardiomyopathy (Knight et al. in Echo Res Prac, 2013). Since the original …

Background Cardiac amyloidosis (CA) has been associated with poor outcomes. Screening
studies suggest that CA is overlooked—especially in the elderly. Recent advances in …

Echocardiographic diagnosis of cardiac amyloidosis (CA) is frequently suggested by the
presence of a left ventricular (LV) apical sparing pattern (ASP) on longitudinal strain (LS) …

Patients with ATTR cardiac amyloidosis (ATTR-CA) face rare disease that could negatively
influence psychological well-being with consequences on the course of the disease and …

Cardiac amyloidosis (CA) is a unique disease entity involving an infiltrative process, typically
resulting in a restrictive cardiomyopathy with diastolic heart failure that ultimately progresses …

Background There is growing evidence of coexistence of aortic stenosis (AS) and
transthyretin cardiac amyloidosis (CA). Not screening AS patients at the time of …

Introduction: Cardiac amyloidosis is a disorder caused by the accumulation of abnormal
protein products, amyloid, in the myocardium which subsequently impairs normal heart …

Cardiac amyloidosis is a systemic disease characterized by continuous deposition of
misfolded proteins called amyloid fibrils in the extracellular space which result in restrictive …